We are live on ! Find out more
ATRC icon

AtriCure

223 hedge funds and large institutions have $1.7B invested in AtriCure in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 70 increasing their positions, 82 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

209% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 11

11% more funds holding

Funds holding: 201223 (+22)

6% more capital invested

Capital invested by funds: $1.6B → $1.7B (+$94.6M)

1.93% less ownership

Funds ownership: 98.81%96.88% (-1.9%)

15% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 82

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
223
Holders Change
+22
Holders Change %
+10.95%
% of All Funds
2.93%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
34
Increased
70
Reduced
82
Closed
11
Calls
$1.52M
Puts
Net Calls
+$1.52M
Net Calls Change
+$421K
Name Holding Trade Value Shares
Change
Change in
Stake
Calamos Advisors
226
Calamos Advisors
Illinois
-$397K -12,126 Closed
Norges Bank
227
Norges Bank
Norway
-$342K -10,438 Closed
CCIA
228
Campbell & Co Investment Adviser
Maryland
-$284K -8,681 Closed
D.E. Shaw & Co
229
D.E. Shaw & Co
New York
-$255K -7,776 Closed
B
230
Bailard
California
-$213K -6,500 Closed
Northwestern Mutual Wealth Management
231
Northwestern Mutual Wealth Management
Wisconsin
-$4.1K -125 Closed
CTC
232
Central Trust Company
Missouri
-$1.15K -35 Closed

ATRC Hedge Fund Activity: Q3 2025 in Review

223 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q3 2025, worth a combined $1.7B — up 5.9% from $1.6B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ATRC positions and 11 closed out — a net gain of 23 holders — while 70 added to existing stakes and 82 trimmed.

The largest buyer was Massachusetts Financial Services, opening a new position worth an estimated $14.6M. The largest seller was UBS AM, cutting an estimated $21M.

  • 223 institutional investors held AtriCure (ATRC) as of Q3 2025, up from 201 in Q2 2025.
  • Funds reported $1.7B of AtriCure stock for Q3 2025, up 5.9% quarter-over-quarter.
  • 34 funds opened new AtriCure positions in Q3 2025 and 11 closed out, a net change of +23 holders.
  • The largest AtriCure buyer in Q3 2025 was Massachusetts Financial Services, an estimated $14.6M added.
  • The largest AtriCure seller in Q3 2025 was UBS AM, an estimated $21M sold.

Based on aggregated 13F filings for Q3 2025.